
The week was characterised by two big psoriasis approval stories, while Amgen’s osteoporosis treatment was knocked back. Novartis CEO Joe …

McKinsey & Company discuss how pharma company executives need to seize every opportunity to embed productivity in their thinking and …

In a press conference at the White House, President Trump, alongside representatives from Corning, MSD and Pfizer, announced that 1,000 …

Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …

MSD, known as Merck in North America, has been granted approval for its biosimilar of Sanofi’s diabetes treatment, Lantus. Potentially, …

A blood test has been created that could offer an inexpensive, and less invasive, alternative to current Alzheimer’s disease tests. …

BenevolentAI, a company that uses an artificial intelligence platform to improve drug discovery, has announced the appointment of Nathan Brown …

The European Commission has announced that it has decided to approve Leo Pharma’s Kyntheum (brodalumab), making it the first and …

Daniel Ray, Head of NHS Digital discusses the importance of data usage in the healthcare system and the NHS Digital …

Sanofi is steadily recovering from missing out on Actelion to J&J by making another deal, this time with Ablynx biotech …

NICE has reached a decision in its final appraisal determination of Teva’s Cinqaero (reslizumab), recommending the drug’s use as an …

A three year report by the Care Quality Commission (CQC) has found that though compassionate care is being offered broadly …

GSK’s Emma Walmsley looks set to begin her rejig of the business, as she aims to offload part of its …

An independent steering committee has compiled a report looking at how more can be delivered from the NHS budget, without …

A collaboration between Swiss antibody therapeutics firm Humab BioMed and the University of California, Berkeley has given rise to an …

The FDA has announced that it has chosen to approve Vosevi (sofosbuvir/velpatasvir/voxilaprevir), Gilead’s investigational drug for the treatment of chronic …

Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …

According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …

Jesper Høiland has been revealed as the new President and Chief Executive Officer of Radius. The news comes shortly after …